Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

PHASE4RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 4, 2018

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
ADHDAttention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate

study to determine dose

Trial Locations (4)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

32610

RECRUITING

University of Florida, Gainesville

45229

COMPLETED

Cincinnati Children's Hospital Medical Center, Cincinnati

98105

TERMINATED

Seattle Children's Hospital, Seattle

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

University of Florida

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Seattle Children's Hospital

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER